Search
Pfizer Inc
PFEAdd to Watchlist
24.995USD
+0.175+0.71%
Close 07-23 16:00（ET）Quotes delayed by 15 min
142.45BMarket Cap
18.98P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-23The current earnings forecast score of Pfizer Inc is 6.81, ranking 124 out of 155 in the Pharmaceuticals industry. The average price target is 29.00, with a high of 37.54 and a low of 24.00.
Analyst Rating
Based on
32
analysts
Hold
Current Rating
28.579
Target Price
+14.59%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Pfizer Inc
PFE
32
Biogen Inc
BIIB
38
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Merck & Co Inc
MRK
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Pfizer Inc's expected revenue for the next quarter?
Pfizer Inc's expected revenue is 14.43B.
What is Pfizer Inc's price target?
Analysts forecast that Pfizer Inc's price target is USD 29.00, with the highest forecast at USD 37.54 and the lowest forecast at USD 24.00.
How have Pfizer IncPFE's recent earnings per share performed?
The market expectation was USD 0.47, while Pfizer IncPFE's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD 0.68.
What is the analyst rating for Pfizer Inc?
Based on the ratings of Pfizer Inc's stock from 32 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.